Pfizer Japan To Ban 5,000 Workers From Smoking On The Job (Japan)
This article was originally published in PharmAsia News
As of April, ahead of Pfizer Japan's planned launch of Chantix (varenicline tartrate), its 5,000 employees are to be barred from smoking while on the job. The company already bans smoking at its Shinjuku headquarters, but it plans to ban the activity at sales sites and other locations, and in the company cars used by the 2,400 sales representatives. Pfizer Japan's smoking policy states it is inappropriate for employees of a health care company to smoke. (Click here for more - may require a subscription
You may also be interested in...
TOKYO - Pfizer is hoping to launch its smoking cessation aid Champix (varenicline) in Japan in April after receiving manufacturing and marketing approval from the Ministry of Health Labor and Welfare Jan. 25, Pfizer Japan told PharmAsia News
Teligent has achieved a “pivotal step in our journey toward securing a strong financial future,” according to management, after recapitalizing its significant debt burden and gaining access to more cash.
Pfizer has entered into an agreement with Premier to supply five essential medications to US healthcare providers through Premier’s ProvideGx program. Both companies aim to secure supply of products specifically used by COVID patients.